Open-Label Psilocybin Study in Transdiagnostic Population

Abroad (travel likely)RecruitingPHASE1

Conditions

Transdiagnostic · Depression - Major Depressive Disorder · Anxiety · PTSD Symptoms · PTSD · Substance Use · Substance Use Disorder (SUD) · OCD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Connecticut Mental Health Center - Yale School of Medicine, New Haven, Connecticut, United States
Contact: Study coordinator (Gabby Agin-Liebes, PhD) · enact@yale.edu · (203) 444-1795

Study leads

Benjamin Kelmendi, MD
Principal Investigator
Yale University
Gabrielle Agin-Liebes, PhD
Principal Investigator
Yale University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Mixed Methods Pilot Trial of the STEP Home Workshop to Improve Reintegration and Reduce Suicide Risk for Recently Transitioned Veterans

TBI · Suicide Prevention · Veterans

Abroad (travel likely)Recruiting

Boston, United States

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

Major Depressive Disorder · Obsessive-Compulsive Disorder · Schizophrenia

Abroad (travel likely)RecruitingPHASE2

Sunnyvale, United States · Boston, United States

Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression

Depression · Anxiety

Abroad (travel likely)Recruiting

Badalona, Spain · Barcelona, Spain

Effectiveness of the Group Unified Protocol for Emotional Disorders in Adults in a Public Mental Health Setting

Emotional Disorders · ANXIETY DISORDERS (or Anxiety and Phobic Neuroses) · Depressive Disorder

Abroad (travel likely)Recruiting

Logroño, Spain